Seres Therapeutics (MCRB) Stock Price, Quote, News & History | Benzinga

Seres Therapeutics Inc (MCRB) Stock Price, Quote, News & History

MCRBNASDAQ

Trade with Public

Trade with Public

$4.95

0.193.99%

At close: Aug 27, 5:00 PM EST

$4.70

-0.25-5.05%

After Hours: 7:22 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$4.77

Close

$4.95

Volume / Avg.

22.87K / 91.00K

Day Range

$4.77 - $5.00

52 Wk Range

4.32 - 29.98

Market Cap

$47.21M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

4.74%

Days to Cover

5.42

Recent Seres Therapeutics, Inc. News

Seres Therapeutics Posts Early Data for Cancer Therapy Complication

Seres Therapeutics reported early SER-155 data, with 80% of patients achieving steroid-free clinical response by Day 15.

Vandana Singh

This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page for full coverage.

Avi Kapoor

Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash

Seres stock drops after pausing a key drug study and cutting 30% of staff. The company shifts focus to early-stage programs while seeking funding, extending cash runway into 2026.

Vandana Singh

Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Coty Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-51.26M

Investing Cash Flow (TTM)

187.00K

Financing Cash Flow (TTM)

14.86M

Free Cash Flow (TTM)

-51.30M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-36.21M

Analyst Trends and Forecast

1

Mar

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$88.86M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

23.58

PB Ratio (TTM)

1.38

Earnings Yield % (TTM)

-50.84%

Earnings Yield % (FWD)

-76.26%

EV / EBITDA (TTM)

3.57

Price / EBITDA (TTM)

1.78

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.44

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$15.59M

Debt to Equity

1.64

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.77

Close

$4.95

Volume / Avg.

22.87K / 91.00K

Day Range

$4.77 - $5.00

52 Wk Range

4.32 - 29.98

Market Cap

$47.21M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

4.74%

Days to Cover

5.42

About

Sector

Health Care

Industry

Biotechnology

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimi...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Seres Therapeutics (MCRB) stock?

A

You can purchase shares of Seres Therapeutics (NASDAQ:MCRB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Seres Therapeutics (MCRB) competitors?

A

There are no as such competitors for Seres Therapeutics.

Q

What is the forecast, or price target, for Seres Therapeutics (MCRB) stock?

A

Seres Therapeutics has a consensus price target of $10.19.

Q

What is the current price for Seres Therapeutics (MCRB)?

A

The stock price for Seres Therapeutics (NASDAQ: MCRB) is $4.7 last updated August 27, 2026 at 7:22 AM EDT.

Q

Does Seres Therapeutics (MCRB) pay a dividend?

A

There are no upcoming dividends for Seres Therapeutics.

Q

When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?

A

Seres Therapeutics does not have any upcoming earnings scheduled.

Q

Is Seres Therapeutics (MCRB) going to split?

A

There is no upcoming split for Seres Therapeutics.

Q

What sector and industry does Seres Therapeutics (MCRB) operate in?

A

Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.